Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
2 institutional releases
Published in New England Journal of Medicine · View the paper (DOI)
A new clinical trial found that the bionic pancreas device was more effective at maintaining blood glucose levels within normal range than standard-of-care management among people with type 1 diabetes. The device requires minimal user input and provides more automation, resulting in improved glycemic control.
Coverage from 2 institutions
- Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods University of Texas Health Science Center at San Antonio · Oct 5, 2022 · first to report
- Bionic pancreas improves type 1 diabetes management in kids and adults Ann & Robert H. Lurie Children's Hospital of Chicago · Oct 12, 2022